You are currently viewing a new version of our website. To view the old version click .

Role of Connexins in Hereditary Diseases

This special issue belongs to the section “Molecular Medicine“.

Special Issue Information

Dear Colleagues,

Connexins are a family of transmembrane proteins that form cell–cell channels (gap junctions), enabling the direct passage of ions and small signaling molecules between coupled cells. Connexins have  essential roles in cell differentiation, proliferation, and homeostasis.  In addition to gap junctions, connexins can also form hemi-channels, and recent evidence further suggests involvement in gap junction-independent cellular activities. 

Twenty-two human connexins have been identified, each differing in tissue distribution, expression, and physiological properties.  Mutations in connexins are associated with over 30 inherited genetic diseases, including congenital cataracts, congenital sensorineural hearing loss, non-syndromic deafness, X-linked Charcot–Marie–Tooth disease, hypomyelinating leukodystrophy, Pelizeaus–Merzbacher-like disease, and skin disorders. Within the field of gap junctions, advanced techniques utilizing genetically modified mouse models, optogenetics, exogenous gene delivery systems, and cryo-EM are providing insights into the roles of connexins in normal physiology and diseases as well as potential therapeutics directed at inherited connexin disorders. 

This Special Issue of Biomolecules welcomes the submission of both original research articles and reviews that focus on understanding the mechanisms underlying the role of connexins in inherited genetic diseases.

Dr. Mona M. Freidin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • connexin mutation
  • hereditary disease
  • PMLD
  • CMTX1
  • SNHL

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomolecules - ISSN 2218-273X